PCSS-MOUD Half and Half DEA Training
This training will be split between 2 dates, the first half on 8/4/2025 which will be held virtually and the second half which will be held in person on 8/11/2025 at the address included. To Register for the training please email: [email protected]
PCSS-MOUD Half and Half DEA Training
Training will be hosted virtually To Register, please email [email protected]
8 Hour Live DEA Training
This is a virtual training. To register, please click the “Register Here” button
PCSS-MOUD Half and Half DEA Training
This training is available virtually. To register, please email: [email protected].
Exchange Session 4 – Implement/Sustain
Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.
Exchange Session 3 – Implement/Sustain
Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.